Alpha DNA Investment Management’s Blackrock BLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,657
Closed -$1.78M 164
2023
Q1
$1.78M Buy
2,657
+1,146
+76% +$807K 0.53% 24
2022
Q4
$1.07M Buy
1,511
+378
+33% +$252K 0.38% 94
2022
Q3
$623K Buy
+1,133
New +$742K 0.52% 76
2021
Q2
Sell
-70
Closed -$52K 161
2021
Q1
$52K Sell
70
-11
-14% -$7.98K 0.06% 164
2020
Q4
$58K Buy
+81
New +$53.7K 0.06% 161

Other funds holding BLK

Alpha DNA Investment Management's BLK Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Blackrock (BLK) in Q2 2023, closing a stake of 2,657 shares — an estimated $1.78M sold.

Alpha DNA Investment Management first reported a position in BLK in Q4 2020 and held it in 5 quarters. The position peaked at $1.78M in Q1 2023. 1,853 funds tracked by Wall St. Rank hold BLK as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Blackrock position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,657 Blackrock shares in Q2 2023, an estimated $1.78M.
  • Alpha DNA Investment Management first reported a position in Blackrock in Q4 2020 and held it in 5 quarters.
  • Alpha DNA Investment Management's Blackrock position peaked at $1.78M in Q1 2023.
  • 1,853 funds tracked by Wall St. Rank held Blackrock as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.